Search company, investor...

Predict your next investment

Corporation
INDUSTRIALS | Manufacturing / Metal Fabrication
sdk.co.jp

Investments

7

Portfolio Exits

3

Partners & Customers

10

About Showa Denko

Showa Denko ("SDK"; TSE:4004, US:SHWDF) is a major manufacturer and marketer of chemical products serving a wide range of fields ranging from heavy industry to the electronic and computer industries. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial and high-performance gases and chemicals and high-purity gases and chemicals for the semiconductor industry, and the Inorganics Sector provides ceramics products such as alumina, abrasive, refractory and graphite electrodes and fine carbon products. Today, the Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high-bright LEDs and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components.

Headquarters Location

13-9, Shiba Daimon 1-Chome Minato-ku

Tokyo, 105-8518,

Japan

Want to inform investors similar to Showa Denko about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Showa Denko News

High-Performance Liquid Chromatography Global Market Report 2023

Feb 28, 2023

2023" - https://www.reportlinker.com/p06424027/?utm_source=GNW , Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc., Phenomenex, Jasco Inc., Hamilton Company, Tosoh Corporation, YMC CO Ltd., Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd., Sartorius AG and Mitsubishi Chemical Corporation. The global high-performance liquid chromatography market grew from $5.32 billion in 2022 to $5.79 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The high-performance liquid chromatography market is expected to grow to $7.36 billion in 2027 at a CAGR of 6.2%. The high-performance liquid chromatography market consists of revenues earned by entities by providing HPLC systems, pumps, detectors, and fraction collectors.The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The high-performance liquid chromatography refers to an analytical technique of separating, identifying, and quantifying components in a mixture.The process relies on pumps which are used to move a pressured liquid solvent containing the sample combination through a column containing a solid adsorbent material. This procedure allows for both quantitative and qualitative analysis. North America was the largest region in the high-performance liquid chromatography market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-performance liquid chromatography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The main product of high-performance liquid chromatography are instruments, consumables, and accessories.The instruments product of high-performance liquid chromatography is instrument used to perform holding packing material (stationary phase) and pumping mobile phase in high-performance liquid chromatography. Instruments in high-performance liquid chromatography refer to delivery systems, mobile phase/solvent reservoir, post-column apparatus, detector, data collection, output system, and others, that are applied in clinical research, diagnostics, forensic, and other applications, used by pharmaceutical and biotechnology industries, diagnostic laboratories, food and beverage industry, academic and research institutes and others end-users (environmental, forensic, chemicals and energy). The increasing prevalence of chronic diseases and acute diseases is expected to propel the demand for the high performance liquid chromatography market.Chronic diseases are long-lasting sicknesses that often cannot be healed. However, it is occasionally curable and controllable.The changing lifestyle, eating habits, and not maintaining body weight are the reason for chronic conditions; a few more prolonged chronic infections lead to cancerous risk. Growing exposure to these diseases raises the need for high performance liquid chromatography for a patient to treat complex chronic diseases.For instance, In September 2020, a research report published by American Action Forum identified that the prevalence and cost of chronic disease in the United States are growing and will continue to rise as the disease prevalence among young people and children rises. The increasing total cost of chronic disease in the United States reaches $3.7 trillion each year, approximately 19.6 percent of its gross domestic product, making it a severe issue in healthcare. Therefore increasing prevalence of chronic and acute diseases is driving the growth of the high performance liquid chromatography market. Technological advancement is the key trend that is gaining popularity in the high-performance liquid chromatography market.High-performance liquid chromatography (HPLC) has been frequently utilized for antibiotic analysis as it outperforms conventional microbiological techniques in terms of specificity, sensitivity, and analysis time. Recently, the market has witnessed ion exchange liquid chromatography techniques for detecting glycated hemoglobin (HbA1c) in blood samples.Ion exchange chromatography separates ions and polar compounds based on their affinity for ion exchangers. Major companies operating in high-performance liquid chromatography focus on research and development to develop technologically advanced tools and solutions to strengthen their market position.For instance, In June 2021, Trivitron Healthcare, an India-based company operating in the manufacturing and supply of medical devices, introduced NANO H5 and NANO H110 for the detection of glycated hemoglobin (HbA1c), measures the amount of glucose (sugar) in blood samples using ion exchange liquid chromatography. NANO H5 and NANO H110 are automated HPLC analyzer that offers dual test mode for the HbA1c test and Hb Variant detection. This new high-performance liquid chromatography analyzer detects HbA1c in less than three minutes. These HbA1c analyzers based on HPLC will be utilized to monitor diabetes, thalassemia, and hemoglobin variations. In January 2022, Bruker Corporation, a US-based manufacturer of scientific instruments for molecular and materials research, acquired Prolab Instruments GmbH for an undisclosed amount.Through this acquisition, Bruker Corporation aims to strengthen its product portfolio in proteomics and metabolomics workflows of high-performance mass spectrometry systems and to improve mobile injection unit technology. Prolab Instruments GmbH is a Switzerland-based company operating in high-performance liquid chromatography instruments. The countries covered in the high-performance liquid chromatography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The high-performance liquid chromatography market research report is one of a series of new reports that provides high-performance liquid chromatography market statistics, including high-performance liquid chromatography industry global market size, regional shares, competitors with a high-performance liquid chromatography market share, detailed high-performance liquid chromatography market segments, market trends and opportunities, and any further data you may need to thrive in the high-performance liquid chromatography industry. This high-performance liquid chromatography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Showa Denko Investments

7 Investments

Showa Denko has made 7 investments. Their latest investment was in AMI Automation as part of their Corporate Minority on February 2, 2021.

CBI Logo

Showa Denko Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/5/2021

Corporate Minority

AMI Automation

Yes

1

8/9/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/25/2003

Secondary Market - III

Subscribe to see more

Subscribe to see more

10

4/29/1998

Secondary Market - II

Subscribe to see more

Subscribe to see more

10

12/31/1985

Secondary Market

Subscribe to see more

Subscribe to see more

10

Date

2/5/2021

8/9/2019

12/25/2003

4/29/1998

12/31/1985

Round

Corporate Minority

Series A

Secondary Market - III

Secondary Market - II

Secondary Market

Company

AMI Automation

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

Showa Denko Portfolio Exits

3 Portfolio Exits

Showa Denko has 3 portfolio exits. Their latest portfolio exit was Showa Denko - Lead-Acid Battery Business on July 08, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/8/2021

Divestiture

Showa Denko - Lead-Acid Battery Business

$99M

1

1/27/2021

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

10/6/2019

Acquired - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/8/2021

1/27/2021

10/6/2019

Exit

Divestiture

Divestiture

Acquired - II

Companies

Showa Denko - Lead-Acid Battery Business

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Showa Denko Acquisitions

3 Acquisitions

Showa Denko acquired 3 companies. Their latest acquisition was Hitachi Chemical on November 26, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/26/2019

$99M

Acq - Pending

2

5/29/2019

Subscribe to see more

$99M

Subscribe to see more

10

10/3/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/26/2019

5/29/2019

10/3/2017

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

Note

Acq - Pending

Subscribe to see more

Subscribe to see more

Sources

2

10

10

Showa Denko Partners & Customers

10 Partners and customers

Showa Denko has 10 strategic partners and customers. Showa Denko recently partnered with New Energy and Industrial Technology Development Organization on May 5, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

5/24/2022

Partner

Japan

1

9/28/2021

Client

Japan

Showa Denko agrees long-term SiC epi supply contract with Toshiba

Tokyo-based wafer manufacturer Showa Denko K.K. has concluded a long-term supply contract with Japan 's Toshiba , which makes silicon carbide - based power semiconductor devices , to supply SiC epitaxial wafers for two and a half years .

4

9/13/2021

Client

Japan

Showa Denko Concludes Long-Term Contract to Supply SiC Epitaxial Wafers for ROHM Co., Ltd.

ROHM Co. , Ltd. decided to conclude this ling-term contract because the company appreciated high-quality and stable supply system of SDK 's SiC epi-wafers .

1

9/13/2021

Client

Japan

Subscribe to see more

Subscribe to see more

10

9/9/2021

Partner

Australia

Subscribe to see more

Subscribe to see more

10

Date

5/24/2022

9/28/2021

9/13/2021

9/13/2021

9/9/2021

Type

Partner

Client

Client

Client

Partner

Business Partner

Country

Japan

Japan

Japan

Japan

Australia

News Snippet

Showa Denko agrees long-term SiC epi supply contract with Toshiba

Tokyo-based wafer manufacturer Showa Denko K.K. has concluded a long-term supply contract with Japan 's Toshiba , which makes silicon carbide - based power semiconductor devices , to supply SiC epitaxial wafers for two and a half years .

Showa Denko Concludes Long-Term Contract to Supply SiC Epitaxial Wafers for ROHM Co., Ltd.

ROHM Co. , Ltd. decided to conclude this ling-term contract because the company appreciated high-quality and stable supply system of SDK 's SiC epi-wafers .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

4

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.